ICP-COVERPATCHNCT07018180
Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With Diabetes
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 13 words Show 4 more changesShow less
- Trial sites expanded: 7 → 10 locations
- Study completion pushed from Jan 5, 2027 to Oct 5, 2027
- Secondary endpoints revised (19)
- Study description expanded, about 5 words
Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
- Start date changed from estimate of Jun 15, 2025 to Dec 5, 2025
- Primary completion date: Jul 31, 2026 to not stated
- Study completion date: Jul 31, 2026 to Jan 5, 2027
- Site details revised at 7 of 7 sites
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Comparison of the evolution of blood HbA1c, expressed in percentage points between enrollment and 4 months, in patients living with diabetes, with or without the COVER PATCH CAPTEUR PROTECT solution
Timeframe: 4 months
Secondary (19)
Comparison of the average sensor wear time over 4 months, reported in percentage points relative to the duration of use claimed by the sensor manufacturers
Comparison of the average sensor wear time, in days, over 4 months
Comparison of the percentage (%) of patients for whom the sensor wear duration reached the maximum duration claimed by the manufacturer during the 4-month study period.
Comparison of sensors' number used over 4 months
Comparison of number change events for sensors, categorized by reason for change (detachment, loss of connection, etc.) at 4 months
Show 14 moreShow less
Comparison of change in scores of the Diabetes Treatment Satisfaction Questionnaire status at baseline (DTSQs) and at 4 months (DTSQs and DTSQc)
Comparison of change in scores of the Diabetes Distress Scale (DDS) or the Parent Diabetes Distress Scale (Parent-DDS) at baseline and at 4 months
Assessment of the COVER PATCH CAPTEUR PROTECT satisfaction questionnaire, completed at 4 months
Comparison of the percentage (%) of time spent in closed-loop mode
Comparison of the estimated HbA1c level (%) (collected from CGM plateforms, between baseline and 3 months)
Comparison of the percentage (or average duration) of data captured (collected from CGM plateforms, between baseline and 3 months)
Comparison of the percentage of time spent in the glucose range < 54 mg/dL (collected from CGM plateforms, between baseline and 3 months)
Comparison of the percentage of time spent in the glucose range 54-69 mg/dL (collected from CGM plateforms, between baseline and 3 months)
Comparison of the percentage of time spent in the glucose range 181-250 mg/dL (collected from CGM plateforms, between baseline and 3 months)
Comparison of the percentage of time spent in the glucose range > 250 mg/dL (collected from CGM plateforms, between baseline and 3 months)
Comparison of the percentage of time spent in the target glucose range 70-140 mg/dL (collected from CGM plateforms, between baseline and 3 months)
Comparison of the average glucose level (mg/dL) (collected from CGM plateforms, between baseline and 43months)
Comparison of the daily glycemic coefficient of variation (collected from CGM plateforms, between baseline and 3 months)
Comparison of adverse events' number, serious adverse events, adverse effects related to support solutions, and unexpected serious adverse effects related to support solutions occurring during the follow-up period
Arms and interventions
COVER PATCHExperimental
Participants use their usual continuous glucose monitoring (CGM) sensor with the COVER PATCH adhesive patch during the study.
Standard of careNo intervention
Participants use their usual continuous glucose monitoring (CGM) sensor without the COVER PATCH adhesive patch during the study (standard of care)
Devices: Use of COVER patchs for continuous glucose monitoring sensor
Sites
10 sites in 4 countries
France 7, Guadeloupe 1, Martinique 1, Reunion 1